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The major iron (Fe) sources available to Neisseria gonorrhoeae in the human host are probably transferrin
(TF) and lactoferrin (LF). Although a number of studies have examined Fe uptake by Neisseria meningitidis,
no comparable studies have been done on Fe uptake by the gonococcus from TF and LF. We found that, like
meningococci, gonococci removed Fe from TF and LF in an energy-dependent manner; uptake was repressed
by Fe and did not proceed by a siderophore-mediated uptake system. Unlike published studies examining
meningococcal Fe uptake from TF, our study showed that gonococcal Fe uptake from both TF and LF was
highly efficient; uptake saturated at 1 ,uM protein, and growth with 5% saturated TF and LF occurred at
maximal rates when the protein was present in appreciable concentrations. We conclude that the availability
of protein-bound Fe probably does not limit growth of N. gonorrhoeae in the human body.
With few exceptions, iron (Fe) is essential for microbial
growth (35). Even though Fe is abundant, it is insoluble in an
aqueous aerobic environment at neutral pH (24), and many
free-living organisms have evolved mechanisms to solubilize
the Fe that they require for growth. Many bacteria produce
low-molecular-weight Fe-chelating molecules, termed sider-
ophores, that perform this function (24). Generally, sidero-
phores are of two chemical types, phenolate and hydroxa-
mate (23), although siderophores of other chemical
structures have been identified (23, 27). Considerable evi-
dence linking Fe-scavenging ability to microbial virulence is
available (35); for instance, invasive strains of Escherichia
coli which produce the dihydroxamate siderophore aerobac-
tin (34) depend on Fe uptake via this siderophore to cause
invasive disease (34).
In aqueous, aerobic conditions at neutral pH, Fe (as the
ferric hydroxide) is extremely insoluble (Ks < 10-38 M) (23).
Environments outside the human body limit biological Fe
availability by this extreme insolubility; pathogens which
survive outside the human body are generally capable of
producing Fe-solubilizing siderophores to obtain Fe. The
availability of Fe in humans, however, is not limited by
insolubility of the cation but by its sequestration on Fe-
binding proteins. In serum and interstitial fluid, Fe is bound
to transferrin (TF); the concentration of unbound Fe in
plasma has been estimated to be approximately 10' ,uM
(35), which is well below the 0.4 to 4.0 ,uM (35) required for
the growth of most microbes. In breast milk, semen, and
mucosal secretions, Fe is bound to the closely related
protein lactoferrin (LF). Both TF and LF bind Fe avidly (35)
and are only partly Fe saturated in vivo (12, 35). Mickelsen
and Sparling showed that all tested strains of Neisseria
gonorrhoeae would grow with 25% Fe-saturated TF as their
only source of Fe (20); about 60% of gonococcal strains were
able to use LF as a sole Fe source (19).
However, TF and LF are not the only Fe sources available
in vivo to invading microbes. Free hemoglobin may, be
available, particularly on vaginal mucosa during meises.
Free hemoglobin or hemoglobin bound to haptoglobin can be
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used by most gonococci for growth (11, 20), albeit less well
than other Fe sources (11). Gonococci also utilize free heme
for growth (20, 39), but when heme is complexed to hemo-
pexin or albumin, it cannot be used by meningococci or
gonococci (11). Gonococci grow with exogenous aerobactin
as a sole Fe source (12, 37); this could be physiologically
relevant in certain microbiologically complicated niches,
such as the pharynx or rectum. 14owever, the major Fe
sources available to the gonococcus are probably TF and
LF, and it is probably these two major Fe sources which
commonly support this pathogen during human infection.
Archibald and DeVoe (3) and Simonson et al. (29) de-
scribed many of the salient biochemical features of uptake of
Fe from TF by the related pathogen Neisseria meningitidis.
Meningococcal utilization of transferrin carrying Fe (Fe-TF)
proceeded by an energy-dependent (4, 29) mechanism which
was repressed by prior growth in Fe (29). High-affinity Fe
uptake from TF was dependent on contact of TF with the
meningococcal surface (3, 29) and did not result in intracel-
lular accumulation ofTF during Fe uptake (29); importantly,
meningococcal TF utilization did not seem to depend on
siderophore production, since these studies were unable to
demonstrate the presence of such compounds in culture
supernatants of Fe-stressed meningococci (3, 29). Most
studies which have examined Fe uptake by N. gonorrhoeae
have concluded that the gonococcus probably does not
produce siderophores (20, 26, 36) and internalizes Fe di-
rectly from TF and LF, possibly by a receptor-mediated
event, as has been suggested for N. meningitidis (29). Thus,
we wished to determine whether Fe uptake from TF by the
gonococcus is similar to that reported for N. meningitidis.
Additionally, because Fe uptake from Fe-LF has not been
studied extensively, we compared Fe uptake from this Fe
source with that from Fe-TF.
MATERIALS AND METHODS
Strains and media. N. gonorrhoeae FA19 has been the
standard strain used in this laboratory for over a decade.
FA19 is serum resistant and antibiotic sensitive (28), and it
contains P.IA (principal outer membrane protein from sero-
group WI [10]); it has caused disseminated disease in a
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laboratory worker (unpublished data). FA19 uses both TF-
and LF-bound Fe (20). E. coli HB101 is a standard labora-
tory derivative of E. coli K-12 which produces the phenolate
siderophore enterochelin. E. coli LG1315 (obtained from P.
Williams, Leicester, United Kingdom) does not produce
enterochelin but does synthesize and utilize aerobactin (34).
Deferrated defined liquid medium (DDL), which contains
<0.07 ,uM iron, and defined agar medium, which contains
approximately 2.0 ,uM iron, have been described elsewhere
(20). The dialysis bag experiments were performed in a
modified Chelex-treated defined medium (CDM), which was
described previously (37). Glassware was acid washed to
remove Fe, as described elsewhere (20).
Iron-binding proteins and iron compounds. Human TF and
LF were obtained commercially (Sigma Chemical Co.). TF
was >98% pure, and LF was >90% pure, as estimated by
the supplier and confirmed by us in sodium dodecyl sulfate-
polyacrylamide gel electrophoresis. These proteins were
dissolved in 40 mM Tris-150 mM NaCl-10 mM NaHCO3
buffer (pH 8.6) and then partially saturated by the addition of
either unlabeled iron or 55Fe (New England Nuclear Corp.)
as previously described (20). Percent saturation was con-
firmed by the Ferrozine assay for iron (32); protein concen-
tration was estimated by the method of Bradford (7), with
reagents from Bio-Rad Laboratories. Desferrioxamine (DF)
was from Ciba Pharmaceutical Co.
Iron uptake studies. Organisms were passaged overnight
on defined agar medium and then suspended in 10 ml of fresh
DDL with 20 mM sodium bicarbonate to an optical density
of approximately 5 Klett units. Cultures were grown in a
37°C shaker with a 5% CO2 atmosphere. Growth was mon-
itored by reading optical density in a Klett-Summerson
spectrophotometer (540-nm filter). Cells were harvested
when they began to show signs of growth limitation com-
pared with cells in a control flask containing 20 ,uM
Fe(NO;)3, usually after about 4 h of incubation. Fe uptake
from [AFe]TF or [55Fe]LF was determined as previously
described (D. W. Dyer, W. McKenna, J. Woods, and P. F.
Sparling, Microb. Pathogen., in press).
For the double-label uptake experiment, purified TF was
first saturated with 59Fe (Amersham Corp.) by ferric nitrilo-
triacetate (16). The saturated protein was then radiolabeled
with 1251 (Amersham) by means of myeloperoxidase (2) and
passed through a Sephadex G-25 column equilibrated with 10
mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesul-
fonic acid)-150 mM NaCl-10 mM NaHCO3 buffer (pH 7.4)
to remove unincorporated 59Fe and 1251.
Dialysis bag experiments. Log-phase bacteria were inocu-
lated into 20 ml of CDM in a 250-ml sidearm flask; the flask
also contained a dialysis sac (Spectrapor; molecular weight
cutoff, 3,500) into which was placed 0.4 ml ofCDM contain-
ing 4 mg of 50% Fe-saturated TF. Control flasks contained
the same amount of 50% saturated Fe-TF in CDM. Growth
at 37°C in a rotary shaker with 5% added CO2 was monitored
as previously described. In certain experiments, [55Fe]TF
(50% saturated, 4 mg) was placed in the dialysis sac to
determine rates of release of Fe from TF as a result of
inoculation of various bacteria into the CDM surrounding
the dialysis sac. In some experiments, filter-sterilized culture
supernatants from gonococci or E. coli grown in CDM were
placed outside the dialysis bag. Release of Fe into the
medium was monitored by removing 100-,lI samples from
the culture at regular intervals and assaying them for s5Fe by
liquid scintillation counting.
Removal of Fe from LF by DF. We tested removal of Fe
from LF by DF by monitoring A466 and A428 during the 2-h
incubation of 1 mM DF and 10 FiM 95% saturated LF in DDL
supplemented with 10 mM NaHC03.
RESULTS
Effects of Fe limitation on gonococcal growth and Fe uptake.
When log-phase cells of strain FA19 were diluted into fresh
DDL or DDL containing 20 ,uM Fe(NO3)3, gonococci grew
at identical rates for two or three doublings, at which time
growth of Fe-limited gonococci began to slow dramatically
(data not shown). When assayed for Fe uptake from
[55Fe]TF or [55Fe]LF, gonococci rapidly accumulated "Fe
from both proteins (Fig. 1). Washing gonococci to remove
growth medium did not affect these results, suggesting that
gonococci did not condition the defined medium in any way
that enhanced the ability of FA19 to internalize 5sFe from TF
or LF. Accumulation of "sFe was repressed by prior growth
in DDL containing excess Fe (data not shown), similar to Fe
repression of uptake observed for N. meningitidis (29, 30)
and other microorganisms (8, 27, 31). Accumulation of "sFe
from ferric dicitrate complexes was similarly repressed by
Fe (data not shown).
The ability of gonococcal strain FA19 to remove Fe from
TF and LF was also markedly inhibited in the presence of
KCN and other respiratory poisons (Fig. 1 and data not
shown). KCN-inhibitable uptake was linear for at least 20
min and then reached a plateau (Fig. 1 and data not shown).
For this reason, measurements taken at 10 and 20 min were
considered indicative of initial rates of uptake. Fe binding in
the presence of KCN probably represented adherence of the
labeled TF or LF to the cell surface and to the cellulose
acetate membrane filters. Thus, the KCN-inhibitable frac-
tion of 5sFe binding probably represented active transport of
iron into the cell, as DeVoe and co-workers concluded for
the meningococcus (5, 29, 30). In the remainder of our
experiments, we used KCN inhibition to assess the fraction
of "sFe accumulated by gonococci that was actually inter-
nalized. This fraction was considered the uptake.
Direct interaction of gonococci with Fe-binding proteins a





















FIG. 1. [55Fe]TF and [55Fe]LF bound to membrane filters when
gonococcal Fe uptake occurred in the presence and absence of 10
mM KCN. Symbols: 0, TF + KCN; A, LF + KCN; 0, TF - KCN;
A, LF - KCN.
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FIG. 2. Growth of FA19 in 20 ml of CDM when 4.0 mg of 50%
Fe-saturated TF was added to the medium (0) or was sequestered
inside a 3,500-molecular-weight exclusion limit dialysis sac (0).
Growth in CDM without supplements is also shown (A).
concerning whether gonococci internalize Fe by a sidero-
phore-mediated mechanism (13, 40) or whether non-sidero-
phore-mediated uptake is responsible for removal of Fe from
TF and LF (20, 26, 36). Although gonococci are capable of
rapid and extensive growth in a defined medium containing
50% saturated Fe-TF (Fig. 2) or Fe-LF (data not shown), we
found that when Fe-TF was contained within a dialysis bag,
gonococcal growth was limited, even compared with that of
a control with no added TF (Fig. 2). The growth limitation
imposed by 50% saturated Fe-TF inside the dialysis mem-
brane presumably resulted from scavenging by TF of the
small amounts of soluble Fe in the defined medium; in other
experiments, growth-limited gonococci began to grow imme-
diately when the dialysis sac containing Fe-TF was deliber-
ately punctured with a sterile needle to release Fe-TF (data
not shown), suggesting that there were no inhibitory sub-
stances in the TF or the dialysis bag which could cause
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coccal surface and the Fe carrier protein seemed to be
required for growth in Fe-depleted medium. Culture super-
natants of Fe-stressed FA19 were also assayed to determine
whether this medium could mobilize 55Fe bound to TF or LF
within a dialysis bag (Fig. 3). In these experiments, we used
spent culture supernatants obtained from growth of E. coli
LG1315 as a positive control for the presence of sidero-
phores in CDM. E. coli LG1315 produces the dihydroxamate
siderophore aerobactin (34), which is a siderophore that both
gonococci and meningococci can use for growth (12, 37).
Spent culture supernatant of LG1315 was able to mobilize
large amounts of sFe from TF (Fig. 3A) under conditions in
which gonococcal culture supernatant was completely inac-
tive (Fig. 3A). Similar results were obtained when a dialysis
bag with a 12,000-molecular-weight exclusion limit was used
(data not shown). Also, culture supernatants from E. coli
HB101, which produces the siderophore enterochelin (23),
mobilized significant amounts of "5Fe from TF (data not
shown). Culture supernatant from Fe-stressed FA19 was
incapable of mobilizing 5Fe from LF contained within a
dialysis bag (Fig. 3B). Surprisingly, aerobactin also was
unable to remove 5sFe from LF (Fig. 3B). Thus, we did not
detect any gonococcal siderophore activity with this assay,
and a siderophore suggested as playing a role in the uptake of
Fe from LF by LF- gonococci (37) did not mobilize appre-
ciable amounts of Fe from this carrier protein under these
experimental conditions.
The fate of TF during Fe uptake by Fe-starved FA19 was
investigated by means of 59Fe-1251-double-labeled TF. Up-
take of 59Fe was rapid and extensive, but there was little net
incorporation of 125I (Fig. 4). This indicated that Fe uptake
occurred without irreversible binding of TF to the cell and
that there was no net accumulation of TF by FA19. Simi-
larly, [125I]LF reversed Fe limitation of FA19 in DDL
without net accumulation of 125I by the cells (data not
shown). No gross degradation ofTF or LF as a consequence
of interaction with FA19 was evident, as shown by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis of total
medium proteins following Fe uptake (data not shown).
We also used the potent Fe chelator DF to compete
against 55FeCl3, [55Fe]TF, or [55FeILF, using 0.5 ,uM labeled
FB
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FIG. 3. Transport of TF-bound (A) and LF-bound (B) "Fe from within a 3,500-molecular-weight exclusion limit dialysis bag suspended
in spent culture medium (CDM), obtained from prolonged iron-depleted growth of FA19 (0) or E. coli LG1315 (A). Bound "Fe in a dialysis
















FIG. 4. Uptake of 59Fe and 1251 from [59Fe-125I]TF by FA19.
Cells were added to DDL containing 0.6 ,uM 50% saturated [59Fe-
1251]TF. Samples (200 pul) were collected on filters and washed
extensively. Counts per minute bound to the filters were determined
separately for 59Fe (0) and 1251 (0).
Fe in each case. DF rapidly chelates soluble Fe and cannot
be used by gonococci as a source of Fe (20). DF (1.0 mM)
was unable to remove Fe from 10 ,uM LF during a 2-h
incubation (data not shown). DF at 5 puM almost totally
abolished uptake of FeCl3 but had much less effect on uptake
from either TF or LF (Fig. 5). A 100-fold molar excess ofDF
reduced Fe uptake from TF or LF only by about 50%. Thus,
removal of "sFe from TF and LF proceeded by a mechanism
which did not yield an Fe intermediate that was readily
bound by DF.
Highly efficient Fe uptake from TF and LF. We were
curious as to the ability of Fe-limited gonococci to remove
Fe from TF and LF as a function of the Fe saturation of each
protein. Holbein (14) suggested that meningococcal bactere-
mia in experimentally infected mice is limited by the hypo-
ferremic response (35), in which Fe levels on TF drop
dramatically. Additionally, EF appears normally to carry
only small amounts of Fe in vivo (12). However, if ability to
utilize TF or LF as an Fe source i$ crucial to gonococcal
pathogenesis, it might not be surprising that Fe could be
removed efficiently even at these low levels of Fe saturation.
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FIG. 5. Inhibition by DF of "Fe uptake from 0.5 p.M 55FeCl3
(0), 1.0 p.M protein of 25% 55Fe-saturated TF (0), or 1.0 p.M protein
of 25% Fe-saturated LF (A). Values are the means of two to four
experiments in which uptake was measured at 20 min.
uptake as the percentage of available protein-bound "Fe
internalized by gonococci after 20 min. The efficiency of Fe
uptake from either TF or LF was essentially unchanged over
a broad range of Fe saturations (Table 1). FA19 was capable
of removing Fe from TF or LF at saturations as low as 5%.
Uptake of Fe from TF was significantly more efficient than
that from LF at all saturations.
These results suggested that gonococci should be able to
grow normally with only 5% Fe-saturated TF or LF as sole
source of required Fe, if enough of the 5% saturated protein
was present. We found this to be true (Fig. 6). When 5%
Fe-saturated TF or LF was added to a final concentration of
5 ,uM protein, growth of FA19 was limited. However, when
5% Fe-saturated TF or LF was added to a concentration of
25 ,uM, growth was equal to that obtained with 25% Fe-
saturated TF or LF added to a concentration of 5 ,uM protein
or with 20 ,uM Fe(NO3)3. In other words, growth with Fe-TF
or Fe-LF was dependent on the amount of Fe available
rather than the saturation level of the protein.
The rate of uptake of 5sFe by FA19 from either TF or LF
was saturable, with maximal uptake at about 1.0 ,uM of
either 50% Fe-saturated protein (Fig. 7); this represented
saturation at 1.0 ,uM Fe. Uptake of Fe from TF was always
greater than from LF. Nearly identical results were obtained
with 25% and 100% Fe-saturated TF and LF. The curve for
saturation of "sFe uptake from ferric citrate was almost
identical to that for TF, with apparent saturation at about 1
,uM ferric citrate; however, total uptake from [55Fe]ferric
citrate was about fivefold greater than for TF (data not
shown).
DISCUSSION
The results reported here were similar in many respects to
earlier experiments with meningococci performed by DeVoe
and co-workers. As was the case with meningococci (5, 29,
30), gonococcal use of Fe was energy requiring and was
repressed by prior growth in Fe but derepressed after two or
three mass doublings in Fe-deficient medium. It did not
involve production of a detectable siderophore and seemed
to require direct contact with either TF or LF, since a
dialysis membrane prevented use of Fe on either TF or LF.
Unexpectedly, we found that aerobactin was unable to
efficiently remove Fe from [55Fe]LF under conditions in
which 55Fe bound to TF was readily solubilized by this
siderophore. This may be due in part to the differences in
avidity between LF and TF for Fe. Aisen and Leibman
found that Fe binding to LF was almost 300 times stronger
than to TF (1), independent of the effects of pH on Fe
binding to the two proteins. Alternatively, the inability of
aerobactin to remove significant amounts of 55Fe from LF
TABLE 1. Efficiency of Fe uptake from LF and TF as a function
of percent Fe saturation
% Fe Efficiency' of Fe uptake from:
saturation LFb TFb
<5 0.28 ± 0.21 0.99 ± 0.67c
10 0.27 ± 0.21 0.59 ± 0.14
25 0.25 ± 0.17 0.36 ± 0.20
50 0.19 ± 0.15 0.42 ± 0.33
>95 0.29 ± 0.18 0.48 ± 0.16
a Efficiency = percent available "Fe taken up at 20 min by Fe-starved
FA19 cells. Each value represents the mean of at least six experiments.
b LF and TF concentrations were 13 ,uM protein.
'P < 0.05 relative to other values for TF (Student's t test).
INFECT. IMMUN.
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FIG. 6. Growth of FA19 in CDM in the presence of LF (A) and TF (B) at various degrees of Fe saturation. Symbols: 0, inorganic iron
(20 ,uM); x, 5% saturated LF or TF (25 ,uM); V, 25% saturated LF or TF (5 ,uM); A, 5% saturated LF or TF (5 FM); 0, apolactoferrin or
apotransferrin.
could reflect subtle differences in interaction between aero-
bactin and the two highly similar Fe-binding proteins. Such
interactions may be sensitive to ionic strength (38), pH, or
the presence of specific counterions. Because about 40% of
gonococci tested were unable to use Fe-LF for growth in
vitro (19), it is unclear what Fe source these strains use for
growth on a mucosal surface. Although they are not defini-
tive proof, these results suggest that exogenously supplied
dihydroxamate siderophores such as aerobactin may not be
capable of efficiently mobilizing Fe from LF and may not
provide an alternative Fe source on the mucosal surface for
LF- gonococci. However, more work needs to be done,
including the construction of gonococcal mutants unable to
utilize aerobactin, to determine the importance of aerobac-
tin-mediated Fe uptake for gonococci.
Gonococci were extremely efficient at using TF or LF as
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FIG. 7. Uptake t standard deviation after 20 min of s5Fe by
Fe-starved FA19 from 50% Fe-saturated TF or LF expressed as a
function of the concentration of TF (0) or LF (A).
LF or TF was sufficient to support normal growth in vitro, as
long as enough protein (about 25 ,uM under these in vitro
conditions) was provided to supply the required amounts of
Fe. Concentrations of TF in vivo are usually well over 25
,uM, and TF is usually saturated to 25% or more (35).
Gonococci thus should be able to acquire all required Fe
from TF in serum. Concentrations of LF on mucosal sur-
faces have not been as well studied; estimates of cervical-
vaginal LF concentrations range from <1 to >10 ,uM (9a).
During inflammation, localized LF concentrations undoubt-
edly increase (33). LF is thought to be quite Fe unsaturated
in vivo (12), but little is known about LF Fe saturation on
genital mucosa. However, FA19 was capable of using LF of
very low saturation levels, suggesting that Fe availability
might not limit gonococcal growth appreciably for LF+
strains.
The biochemical mechanisms of release of Fe from TF or
LF and of transport across the cell membranes are unknown.
Transport of Fe was not accompanied by equivalent cellular
uptake of TF, as is the case with eucaryotic use of Fe-TF
(15), since extensive uptake of s9Fe from TF was not
accompanied by significant incorporation of [1251]TF (Fig.
4). These results imply that there is a cycle consisting of
Fe-TF binding to the cell surface followed by Fe transport,
release of Fe-unloaded TF, and binding of another molecule
of Fe-TF. Consistent with this model, DF was unable to
prevent Fe uptake from TF, possibly because Fe was
released from TF either in a cell compartment from which
DF was excluded or onto a cell Fe carrier molecule that was
resistant to the chelating power of DF. If Fe were released
from TF or LF by reduction to Fe2+, DF also would have
little effect, since it has very low affinity for ferrous ion (23).
Ferric reductase activity has been detected in gonococci
(A. E. Lefaou and S. A. Morse, Abstr. Annu. Meet. Am.
Soc. Microbiol. 1987, D-20, p. 75).
Gonococcal Fe uptake from TF saturated at only about 1
puM TF, whereas meningococci evidenced saturation at
about 30 puM TF (29). Reasons for these differences are
unclear and could be multiple, including use of different
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determine the mechanisms of Fe uptake from TF and LF,
including the relative binding affinities of apotransferrin,
Fe-TF, and Fe-LF, and to determine whether there are
specific surface receptors for binding TF, LF, or other Fe
sources. Since the gonococcal (and meningococcal) cell
surface is covered by polyphosphate (25) and is negatively
charged, basic proteins such as TF and LF could bind
nonspecifically to this surface, close enough for release of Fe
by a reductase (see above) or possibly by PP1 (17) or
polyphosphate (18; S. E. H. West, R. Penniall, and P. F.
Sparling, Proceedings of the Fifth International Conference
on Pathogenic Neisseriae, in press).
In earlier experiments, West and Sparling showed that Fe
starvation results in increased expression of several gono-
coccal membrane proteins (36). Meningococci (9; Dyer et
al., in press) and many other bacteria (24) also exhibit
several Fe-repressible membrane proteins (FeRPs). Some of
the neisserial FeRPs are common antigens (6, 21), and
humans make antibodies against them during infection (6,
21). In other bacteria, FeRPs serve as receptors for binding
specific Fe compounds (24). By analogy, gonococcal FeRPs
might also play specific roles in binding TF or LF or in the
release of Fe and transport of Fe across the membrane.
Meitzner et al. (22) have shown that a 37-kilodalton FeRP
binds Fe when the protein is purified from Fe-stressed
gonococci and meningococci. The 37-kilodalton FeRP is
present in all gonococcal and meningococcal strains exam-
ined (21). However, it is not clear whether Fe binding by the
37-kilodalton FeRP represents a step in Fe uptake. We are
presently using biochemical and genetic approaches to an-
swer questions concerning the mechanisms of Fe scavenging
by gonococci and meningococci.
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